Table 1.
Standard membrane feeding assays with PPLP2(−)
| Feed | Infections/total (n) | Oocysts/midguts (mean ± SD, range) | Infection rate (%) | Change in transmission (%) | |
|---|---|---|---|---|---|
| Experimental setting 1: PPLP2(−) versus WT | |||||
| Feed 1 | Mock control | 10/10 | 23 ± 12, 8–52 | 100 | / |
| PPLP2(−) | 5/10 | 1 ± 2, 0–7 | 50 | −50 | |
| Feed 2 | Mock control | 8/10 | 6 ± 4, 0–11 | 80 | / |
| PPLP2(−) | 0/10 | 0 ± 0, 0 | 0 | −100 | |
| Feed 3 | WT | 20/20 | 70 ± 30, 22–148 | 100 | / |
| PPLP2(−) | 4/20 | 0 ± 0, 0–1 | 20 | −80 | |
| Feed 4 | WT | 19/20 | 33 ± 20, 0–69 | 95 | / |
| PPLP2(−) | 17/20 | 3 ± 3, 0–12 | 85 | −11 | |
| Feed 5 | WT | 20/20 | 42 ± 22, 5–107 | 100 | / |
| PPLP2(−) | 19/20 | 5 ± 3, 0–13 | 95 | −5 | |
| Experimental setting 2: Equinatoxin II (EqII) treatment | |||||
| Feed 1 | WT | 17/20 | 8 ± 8, 0–30 | 85 | / |
| WT + EqtII | 18/20 | 11 ± 9, 0–26 | 90 | +6 | |
| PPLP2(−) | 4/20 | 0 ± 1, 0–2 | 20 | / | |
| PPLP2(−) + EqtII | 14/20 | 1 ± 1, 0–4 | 70 | +250 | |
| Feed 2 | WT | 17/20 | 5 ± 5, 0–17 | 85 | / |
| WT + EqtII | 15/20 | 4 ± 3, 0–10 | 75 | −12 | |
| PPLP2(−) | 1/20 | 0 ± 0, 0–1 | 5 | / | |
| PPLP2(−) + EqtII | 5/20 | 0 ± 1, 0–2 | 25 | +400 | |